{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:37:17Z","timestamp":1768700237772,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T00:00:00Z","timestamp":1332201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10633-012-9320-7","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T04:04:39Z","timestamp":1332129879000},"page":"197-209","source":"Crossref","is-referenced-by-count":29,"title":["Electroretinographic (ERG) responses in pediatric patients using vigabatrin"],"prefix":"10.1007","volume":"124","author":[{"given":"Anne","family":"Moskowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,20]]},"reference":[{"key":"9320_CR1","unstructured":"Sabril (vigabatrin) Advisory Committee Briefing Document (2009) Ovation Pharmaceuticals. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee\/UCM153780.pdf"},{"key":"9320_CR2","first-page":"699","volume-title":"Pediatric epilepsy: diagnosis and therapy","author":"G Kramer","year":"2008","unstructured":"Kramer G, Wohlrab G (2008) Vigabatrin. In: Pellock JM, Bourgeois BFD, Dodson WE (eds) Pediatric epilepsy: diagnosis and therapy. Demos Medical Publishing, New York, pp 699\u2013709"},{"key":"9320_CR3","volume-title":"The ocular side-effects of vigabatrin (Sabril)","author":"Royal College of Ophthalmologists","year":"2008","unstructured":"Royal College of Ophthalmologists (2008) The ocular side-effects of vigabatrin (Sabril). Information and Guidance for Screening, London"},{"key":"9320_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/01658100903582498","volume":"34","author":"RC Sergott","year":"2010","unstructured":"Sergott RC, Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, Foroozan R, Sagar SM (2010) Evidence-based review of recommendations for visual function testing in patients treated with vigabatrin. Neuro-ophthalmology 34:20\u201335","journal-title":"Neuro-ophthalmology"},{"key":"9320_CR5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. BMJ 314:180\u2013181","journal-title":"BMJ"},{"key":"9320_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.55.1.40","volume":"55","author":"MA Johnson","year":"2000","unstructured":"Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR (2000) Visual function loss from vigabatrin: effect of stopping the drug. Neurology 55:40\u201345","journal-title":"Neurology"},{"key":"9320_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1014607331200","volume":"104","author":"HS Graniewski-Wijnands","year":"2002","unstructured":"Graniewski-Wijnands HS, van der Torren K (2002) Electro-ophthalmological recovery after withdrawal from vigabatrin. Doc Ophthalmol 104:189\u2013194","journal-title":"Doc Ophthalmol"},{"key":"9320_CR8","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","volume":"51","author":"MJ Maguire","year":"2010","unstructured":"Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG (2010) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 51:2423\u20132431","journal-title":"Epilepsia"},{"key":"9320_CR9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/11317650-000000000-00000","volume":"23","author":"JM Wild","year":"2009","unstructured":"Wild JM, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, Goldberg I, Goni FJ, Mercier F, Nordmann JP, Safran AB, Schiefer U, Perucca E (2009) Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 23:965\u2013982","journal-title":"CNS Drugs"},{"key":"9320_CR10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.22266","volume":"69","author":"LM Clayton","year":"2011","unstructured":"Clayton LM, Devile M, Punte T, Kallis C, de Haan GJ, Sander JW, Acheson J, Sisodiya SM (2011) Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol 69:845\u2013854","journal-title":"Ann Neurol"},{"key":"9320_CR11","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1167\/iovs.08-3237","volume":"50","author":"S Durbin","year":"2009","unstructured":"Durbin S, Mirabella G, Buncic JR, Westall CA (2009) Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. Invest Ophthalmol Vis Sci 50:4011\u20134016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR12","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1212\/WNL.53.9.2082","volume":"53","author":"NR Miller","year":"1999","unstructured":"Miller NR, Johnson MA, Paul SR, Girkin CA, Perry JD, Endres M, Krauss GL (1999) Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 53:2082\u20132087","journal-title":"Neurology"},{"key":"9320_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1528-1157.2001.49299.x","volume":"42","author":"SR Paul","year":"2001","unstructured":"Paul SR, Krauss GL, Miller NR, Medura MT, Miller TA, Johnson MA (2001) Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia 42:525\u2013530","journal-title":"Epilepsia"},{"key":"9320_CR14","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","volume":"106","author":"H Daneshvar","year":"1999","unstructured":"Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D (1999) Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 106:1792\u20131798","journal-title":"Ophthalmology"},{"key":"9320_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","volume":"55","author":"GF Harding","year":"2000","unstructured":"Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C (2000) Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology 55:347\u2013352","journal-title":"Neurology"},{"key":"9320_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/B:DOOP.0000005337.39947.83","volume":"107","author":"EL Spencer","year":"2003","unstructured":"Spencer EL, Harding GF (2003) Examining visual field defects in the paediatric population exposed to vigabatrin. Doc Ophthalmol 107:281\u2013287","journal-title":"Doc Ophthalmol"},{"key":"9320_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1014644307518","volume":"104","author":"D Besch","year":"2002","unstructured":"Besch D, Kurtenbach A, Apfelstedt-Sylla E, Sadowski B, Dennig D, Asenbauer C, Zrenner E, Schiefer U (2002) Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol 104:151\u2013170","journal-title":"Doc Ophthalmol"},{"key":"9320_CR18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0161-6420(01)00638-8","volume":"108","author":"SG Coupland","year":"2001","unstructured":"Coupland SG, Zackon DH, Leonard BC, Ross TM (2001) Vigabatrin effect on inner retinal function. Ophthalmology 108:1493\u20131496; discussion 1497-8","journal-title":"Ophthalmology"},{"key":"9320_CR19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1014603229383","volume":"104","author":"IF Comaish","year":"2002","unstructured":"Comaish IF, Gorman C, Brimlow GM, Barber C, Orr GM, Galloway NR (2002) The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Doc Ophthalmol 104:195\u2013212","journal-title":"Doc Ophthalmol"},{"key":"9320_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1014679804792","volume":"104","author":"H Jensen","year":"2002","unstructured":"Jensen H, Sjo O, Uldall P, Gram L (2002) Vigabatrin and retinal changes. Doc Ophthalmol 104:171\u2013180","journal-title":"Doc Ophthalmol"},{"key":"9320_CR21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/0883073810390213","volume":"26","author":"B McCoy","year":"2011","unstructured":"McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26:729\u2013733","journal-title":"J Child Neurol"},{"key":"9320_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1014615517996","volume":"104","author":"K Torren van der","year":"2002","unstructured":"van der Torren K, Graniewski-Wijnands HS, Polak BC (2002) Visual field and electrophysiological abnormalities due to vigabatrin. Doc Ophthalmol 104:181\u2013188","journal-title":"Doc Ophthalmol"},{"key":"9320_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1014656626174","volume":"104","author":"CA Westall","year":"2002","unstructured":"Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M (2002) The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Doc Ophthalmol 104:133\u2013149","journal-title":"Doc Ophthalmol"},{"key":"9320_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/B:DOOP.0000005338.51554.e3","volume":"107","author":"S Morong","year":"2003","unstructured":"Morong S, Westall CA, Nobile R, Buncic JR, Logan WJ, Panton CM, Abdolell M (2003) Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Doc Ophthalmol 107:289\u2013297","journal-title":"Doc Ophthalmol"},{"key":"9320_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:DOOP.0000005339.23258.8f","volume":"107","author":"CA Westall","year":"2003","unstructured":"Westall CA, Nobile R, Morong S, Buncic JR, Logan WJ, Panton CM (2003) Changes in the electroretinogram resulting from discontinuation of vigabatrin in children. Doc Ophthalmol 107:299\u2013309","journal-title":"Doc Ophthalmol"},{"key":"9320_CR26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archopht.119.11.1625","volume":"119","author":"DL Mayer","year":"2001","unstructured":"Mayer DL, Hansen RM, Moore BD, Kim S, Fulton AB (2001) Cycloplegic refractions in healthy children aged 1 through 48\u00a0months. Arch Ophthalmol 119:1625\u20131628","journal-title":"Arch Ophthalmol"},{"key":"9320_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00006324-200303000-00012","volume":"80","author":"K Zadnik","year":"2003","unstructured":"Zadnik K, Manny RE, Yu JA, Mitchell GL, Cotter SA, Quiralte JC, Shipp M, Friedman NE, Kleinstein RN, Walker TW, Jones LA, Moeschberger ML, Mutti DO (2003) Ocular component data in schoolchildren as a function of age and gender. Optom Vis Sci 80:226\u2013236","journal-title":"Optom Vis Sci"},{"key":"9320_CR28","first-page":"1158","volume":"26","author":"MA McDonald","year":"1985","unstructured":"McDonald MA, Dobson V, Sebris SL, Baitch L, Varner D, Teller DY (1985) The acuity card procedure: a rapid test of infant acuity. Invest Ophthalmol Vis Sci 26:1158\u20131162","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR29","first-page":"657","volume":"36","author":"SR Salomao","year":"1995","unstructured":"Salomao SR, Ventura DF (1995) Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards. Invest Ophthalmol Vis Sci 36:657\u2013670","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/OPX.0b013e3181a7b3fc","volume":"86","author":"S Agrawal","year":"2009","unstructured":"Agrawal S, Mayer DL, Hansen RM, Fulton AB (2009) Visual fields in children treated with vigabatrin. Optom Vis Sci 86:767\u2013773","journal-title":"Optom Vis Sci"},{"key":"9320_CR31","first-page":"78","volume-title":"Pediatric Ophthalmology and Strabismus","author":"DL Mayer","year":"2004","unstructured":"Mayer DL, Fulton AB (2004) Visual fields. In: Taylor D, Hoyt CS (eds) Pediatric Ophthalmology and Strabismus. Elsevier Saunders, New York, pp 78\u201386"},{"key":"9320_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00154382","volume":"80","author":"N Wali","year":"1992","unstructured":"Wali N, Leguire LE (1992) The photopic hill: a new phenomenon of the light adapted electroretinogram. Doc Ophthalmol 80:335\u2013345","journal-title":"Doc Ophthalmol"},{"key":"9320_CR33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1001\/archopht.121.12.1738","volume":"121","author":"ER Elias","year":"2003","unstructured":"Elias ER, Hansen RM, Irons M, Quinn NB, Fulton AB (2003) Rod photoreceptor responses in children with Smith\u2013Lemli\u2013Opitz syndrome. Arch Ophthalmol 121:1738\u20131743","journal-title":"Arch Ophthalmol"},{"key":"9320_CR34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10633-010-9232-3","volume":"121","author":"D Garry","year":"2010","unstructured":"Garry D, Hansen RM, Moskowitz A, Elias ER, Irons M, Fulton AB (2010) Cone ERG responses in patients with Smith\u2013Lemli\u2013Opitz Syndrome (SLOS). Doc Ophthalmol 121:85\u201391","journal-title":"Doc Ophthalmol"},{"key":"9320_CR35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0161-6420(92)31810-X","volume":"99","author":"S Wongpichedchai","year":"1992","unstructured":"Wongpichedchai S, Hansen RM, Koka B, Gudas VM, Fulton AB (1992) Effects of halothane on children\u2019s electroretinograms. Ophthalmology 99:1309\u20131312","journal-title":"Ophthalmology"},{"key":"9320_CR36","first-page":"1588","volume":"41","author":"AB Fulton","year":"2000","unstructured":"Fulton AB, Hansen RM (2000) The development of scotopic sensitivity. Invest Ophthalmol Vis Sci 41:1588\u20131596","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR37","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1167\/iovs.05-0382","volume":"46","author":"RM Hansen","year":"2005","unstructured":"Hansen RM, Fulton AB (2005) Development of the cone ERG in infants. Invest Ophthalmol Vis Sci 46:3458\u20133462","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1113\/jphysiol.1992.sp019111","volume":"449","author":"TD Lamb","year":"1992","unstructured":"Lamb TD, Pugh EN Jr (1992) A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol 449:719\u2013758","journal-title":"J Physiol"},{"key":"9320_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0005-2728(93)90038-H","volume":"1141","author":"EN Pugh Jr","year":"1993","unstructured":"Pugh EN Jr, Lamb TD (1993) Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta 1141:111\u2013149","journal-title":"Biochim Biophys Acta"},{"key":"9320_CR40","first-page":"2948","volume":"35","author":"DC Hood","year":"1994","unstructured":"Hood DC, Birch DG (1994) Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 35:2948\u20132961","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR41","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0042-6989(01)00157-2","volume":"41","author":"TS Aleman","year":"2001","unstructured":"Aleman TS, LaVail MM, Montemayor R, Ying G, Maguire MM, Laties AM, Jacobson SG, Cideciyan AV (2001) Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vis Res 41:2779\u20132797","journal-title":"Vis Res"},{"key":"9320_CR42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0042-6989(01)00026-8","volume":"41","author":"K Wurziger","year":"2001","unstructured":"Wurziger K, Lichtenberger T, Hanitzsch R (2001) On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis Res 41:1091\u20131101","journal-title":"Vis Res"},{"key":"9320_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0042-6989(89)90075-8","volume":"29","author":"NS Peachey","year":"1989","unstructured":"Peachey NS, Alexander KR, Fishman GA (1989) The luminance-response function of the dark-adapted human electroretinogram. Vis Res 29:263\u2013270","journal-title":"Vis Res"},{"key":"9320_CR44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1113\/jphysiol.2004.061523","volume":"556","author":"C Friedburg","year":"2004","unstructured":"Friedburg C, Allen CP, Mason PJ, Lamb TD (2004) Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram. J Physiol 556:819\u2013834","journal-title":"J Physiol"},{"key":"9320_CR45","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/0042-6989(95)00034-W","volume":"35","author":"DC Hood","year":"1995","unstructured":"Hood DC, Birch DG (1995) Phototransduction in human cones measured using the alpha-wave of the ERG. Vis Res 35:2801\u20132810","journal-title":"Vis Res"},{"key":"9320_CR46","first-page":"701","volume":"91","author":"PA Sieving","year":"1993","unstructured":"Sieving PA (1993) Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 91:701\u2013773","journal-title":"Trans Am Ophthalmol Soc"},{"key":"9320_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10633-010-9233-2","volume":"121","author":"DL McCulloch","year":"2010","unstructured":"McCulloch DL, Hamilton R (2010) Essentials of photometry for clinical electrophysiology of vision. Doc Ophthalmol 121:77\u201384","journal-title":"Doc Ophthalmol"},{"key":"9320_CR48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2009.06.003","volume":"28","author":"AB Fulton","year":"2009","unstructured":"Fulton AB, Hansen RM, Moskowitz A, Akula JD (2009) The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 28:452\u2013482. Corrigendum 2010;29:94","journal-title":"Prog Retin Eye Res"},{"key":"9320_CR49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00031305.1986.10475378","volume":"40","author":"GA Whitmore","year":"1986","unstructured":"Whitmore GA (1986) Prediction limits for a univariate normal observation. Am Stat 40:141\u2013143","journal-title":"Am Stat"},{"key":"9320_CR50","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archopht.120.8.1055","volume":"120","author":"LL Cooper","year":"2002","unstructured":"Cooper LL, Hansen RM, Darras BT, Korson M, Dougherty FE, Shoffner JM, Fulton AB (2002) Rod photoreceptor function in children with mitochondrial disorders. Arch Ophthalmol 120:1055\u20131062","journal-title":"Arch Ophthalmol"},{"key":"9320_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","volume":"50","author":"LJ Willmore","year":"2009","unstructured":"Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD (2009) Vigabatrin: 2008 update. Epilepsia 50:163\u2013173","journal-title":"Epilepsia"},{"key":"9320_CR52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1167\/iovs.05-0854","volume":"47","author":"JM Wild","year":"2006","unstructured":"Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE (2006) Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 47:917\u2013924","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(77)90270-9","volume":"45","author":"PJ Schechter","year":"1977","unstructured":"Schechter PJ, Tranier Y, Jung MJ, Bohlen P (1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319\u2013328","journal-title":"Eur J Pharmacol"},{"key":"9320_CR54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1528-1157.2003.04203.x","volume":"44","author":"GJ Sills","year":"2003","unstructured":"Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ (2003) Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44:886\u2013892","journal-title":"Epilepsia"},{"key":"9320_CR55","first-page":"517","volume-title":"Early visual development\u2014normal and abnormal","author":"DC Hood","year":"1993","unstructured":"Hood DC, Birch DG, Birch EE (1993) Use of models to improve hypothesis delineation: A study of infant electroretinography. In: Simons K (ed) Early visual development\u2014normal and abnormal. Oxford University Press, New York, pp 517\u2013535"},{"key":"9320_CR56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/35.8.3298424","volume":"35","author":"DJ Garry","year":"1987","unstructured":"Garry DJ, Coulter HD, McIntee TJ, Wu JY, Sorenson RL (1987) Immunoreactive GABA transaminase within the pancreatic islet is localized in mitochondria of the B-cell. J Histochem Cytochem 35:831\u2013836","journal-title":"J Histochem Cytochem"},{"key":"9320_CR57","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1016\/j.visres.2004.09.002","volume":"44","author":"JG Robson","year":"2004","unstructured":"Robson JG, Maeda H, Saszik SM, Frishman LJ (2004) In vivo studies of signaling in rod pathways of the mouse using the electroretinogram. Vis Res 44:3253\u20133268","journal-title":"Vis Res"},{"key":"9320_CR58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2011.07.030","volume":"72","author":"R Herrmann","year":"2011","unstructured":"Herrmann R, Heflin SJ, Hammond T, Lee B, Wang J, Gainetdinov RR, Caron MG, Eggers ED, Frishman LJ, McCall MA, Arshavsky VY (2011) Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. Neuron 72:101\u2013110","journal-title":"Neuron"},{"key":"9320_CR59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1167\/iovs.03-0657","volume":"45","author":"S Ueno","year":"2004","unstructured":"Ueno S, Kondo M, Niwa Y, Terasaki H, Miyake Y (2004) Luminance dependence of neural components that underlies the primate photopic electroretinogram. Invest Ophthalmol Vis Sci 45:1033\u20131040","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9320_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","volume":"13","author":"D Nie","year":"2010","unstructured":"Nie D, Di Nardo A, Han JM, Baharanyi H, Kramvis I, Huynh T, Dabora S, Codeluppi S, Pandolfi PP, Pasquale EB, Sahin M (2010) Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci 13:163\u2013172","journal-title":"Nat Neurosci"},{"key":"9320_CR61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaapos.2011.08.004","volume":"15","author":"WV Good","year":"2011","unstructured":"Good WV (2011) Measuring field loss in children administered vigabatrin: a problem in search of a solution. J AAPOS 15:411\u2013412","journal-title":"J AAPOS"},{"key":"9320_CR62","doi-asserted-by":"crossref","unstructured":"Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69\u201377","DOI":"10.1007\/s10633-008-9155-4"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-012-9320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-012-9320-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-012-9320-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T16:30:49Z","timestamp":1713717049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-012-9320-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,20]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9320"],"URL":"https:\/\/doi.org\/10.1007\/s10633-012-9320-7","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,20]]}}}